Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer
Centre Jean Bernard · University of North Carolina at Chapel Hill · +4 more institutions
Indexed incrossrefpubmed
Abstract
This study reports 2-year survival outcomes among patients with advanced nonprogressive stage IIA to IV lung cancer randomized to symptom monitoring during chemotherapy via web-based patient-reported outcomes vs standard scheduled imaging after treatment to detect symptomatic recurrence.
Citation impact
565
total citations
- FWCI
- 55.91
- Percentile
- 100%
- References
- 4
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Medicine
- Lung cancer
- Chemotherapy
- Randomized controlled trial
- Stage (stratigraphy)
- Lung
- Internal medicine
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.